IND Exempt Trials No Longer “Deemed” Covered By Medicare, CMS Says

Clinical trials that are exempt from FDA's investigational new drug process would no longer automatically qualify for Medicare coverage under CMS' proposed Clinical Research Policy

More from Archive

More from Pink Sheet